Jubilant Life Q2 net profit at Rs 125 crore

Image
Press Trust of India New Delhi
Last Updated : Oct 28 2017 | 7:42 PM IST
Drug firm Jubilant Life Sciences Ltd today said its consolidated net profit stood at Rs 125.47 crore for the second quarter ended September 30.
The company had posted Rs 143.56 crore net profit after tax for the corresponding period of the previous fiscal, Jubilant Life Sciences said in a filing to BSE.
The company also said that sales/incomes from operations for the current period is not comparable with previous periods, due to Goods and Services Tax (GST) implementation.
Consolidated total income from operations stood at Rs 1649.13 crore in the quarter under review.
Pharmaceuticals revenue was at Rs 860 crore, contributing 52 per cent to the revenues. Life Science ingredients revenue was at Rs 738 crore, representing 45 per of the revenues, the company said.
International revenues were at Rs 1,181 crore, constituting 72 per cent of the revenue for the quarter,it added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 28 2017 | 7:42 PM IST

Next Story